ABBVIE BIOTHERAPEUTICS INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 50205
 
  
 
C07K PEPTIDES 4591
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 990
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 693
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 368
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0348,429 ANTI-cMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEMay 17, 17Dec 07, 17[A61K]
2017/0342,150 METHOD OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIESAug 07, 17Nov 30, 17[A61K, C07K]
2017/0342,169 BISPECIFIC BINDING PROTEINSMay 26, 17Nov 30, 17[A61K, C07K]
2017/0233,481 ANTI-CD25 ANTIBODIES AND THEIR USESMay 03, 17Aug 17, 17[C12P, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914783 Anti-PD-1 antibodies and their usesSep 14, 17Mar 13, 18[C07K]
9815893 Anti-VEGF antibodies and their usesNov 27, 13Nov 14, 17[A61K, C07K]
9815903 DAC HYP compositionsMay 04, 17Nov 14, 17[A61K, C07K]
9809652 Methods of treating progressive forms of multiple sclerosis comprising subcutaneously administering daclizumabAug 08, 12Nov 07, 17[A61K, C07K]
9676860 DAC HYP compositions and methodsJan 21, 15Jun 13, 17[A61K, C07K, A61L]
9587007 CTLA4 proteins and their usesOct 27, 14Mar 07, 17[A61K, C07K]
9340619 DAC HYP compositions and methodsMar 27, 15May 17, 16[A61K, C07K, A61L]
9315573 Anti-TNF-alpha antibodies and their usesFeb 28, 14Apr 19, 16[A61K, C07K]
9279016 Methods for identifying antibodies with reduced immunogenicitySep 18, 13Mar 08, 16[A61K, G01N, C40B, C07K]
9260528 DAC HYP compositions and methodsJun 09, 15Feb 16, 16[A61K, C07K, A61L]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0206,734 COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMAAbandonedApr 06, 16Jul 21, 16[A61K, C07K]
2015/0259,425 COMPOSITIONS AND METHODS FOR PRODUCING GLYCOPROTEINSAbandonedSep 27, 13Sep 17, 15[C07K]
2015/0010,538 ANTI-CD25 ANTIBODIES AND THEIR USESAbandonedMar 14, 14Jan 08, 15[A61K, C07K]
2015/0010,539 ANTI-CD25 ANTIBODIES AND THEIR USESAbandonedMar 14, 14Jan 08, 15[A61K, C07K]
2014/0377,253 FC VARIANTSAbandonedMar 14, 14Dec 25, 14[C07K]
2014/0295,497 VECTORS AND HOST CELLS COMPRISING A MODIFIED SV40 PROMOTER FOR PROTEIN EXPRESSIONAbandonedNov 30, 11Oct 02, 14[C12P, C12N]
2014/0154,255 ANTI-VEGF ANTIBODIES AND THEIR USESAbandonedNov 26, 13Jun 05, 14[C07K]
2013/0338,038 METHOD OF SCREENING COMPLEX PROTEIN LIBRARIES TO IDENTIFY ALTERED PROPERTIESAbandonedDec 19, 08Dec 19, 13[C40B]
2012/0301,429 DAC HYP COMPOSITIONS AND METHODSAbandonedMay 25, 12Nov 29, 12[A61K, A01N, C12P, C12N, A61P, A61L, C07K]
2012/0135,005 ANTI-TNF-a ANTIBODIES AND THEIR USESAbandonedApr 16, 10May 31, 12[A61K, C12P, C12N, A61P, C07K]
2009/0238,827 THERAPEUTIC USE OF ANTI-CS1 ANTIBODIESAbandonedMar 10, 09Sep 24, 09[A61K]
2005/0025,763 Therapeutic use of anti-CS1 antibodiesAbandonedMay 07, 04Feb 03, 05[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.